
Alexmed Pharmaceuticals Private Limited
About Alexmed Pharmaceuticals Private Limited
Data last updated:
Alexmed Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India, recognised as a startup by DPIIT. It operates in the social services and community development segment of the non-profit sector. It was incorporated on 21 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U85300BR2019PTC043080. Its GSTIN is 10AASCA6439Q1Z3 (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Suman Prasad Sharma and Nishi Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Suman Prasad Vill – Jinpura Tola – Jinpura Wardi – 12 Panch – Raghopur, Patna, Bihar, India – 801111.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.91 Lakh, a decline of 27% compared to the previous year. For the same year it recorded a net profit of ₹7,900 (net margin 0.9%) and EBITDA of ₹11,930 (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
Company details
Recognitions & Rankings of Alexmed Pharmaceuticals
Contact details
Alexmed Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Suman Prasad Vill – Jinpura Tola – Jinpura Wardi – 12 Panch – Raghopur, Patna, Bihar, India – 801111
- IndustryNon-Profit Organizations, Social Work
To see the full contact details of Alexmed Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alexmed Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Alexmed Pharmaceuticals Private Limited, buy the company report.
Financials of Alexmed Pharmaceuticals Private Limited
FY 2025 filings availableAlexmed Pharmaceuticals Private Limited reported revenue of ₹8.91 Lakh (down 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 27% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA rose 196% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11,930 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,900 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alexmed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alexmed Pharmaceuticals Private Limited
Alexmed Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Prasad Sharma | Director | 21 Aug 2019 | 7 Years 2 Months | Current |
| Nishi Kumari | Director | 21 Aug 2019 | 7 Years 2 Months | Current |
| Mukul Anand Shankar | Additional Director | 12 Jul 2021 | 5 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Alexmed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alexmed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alexmed Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AASCA6439Q1Z3 | Bihar | Active | 07 Sep 2019 |
To see the full GST registrations and return filing status of Alexmed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alexmed Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Mukul Anand Shankar was appointed as Additional Director on 12 Jul 2021.
Frequently asked questions
Alexmed Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in social work, within the non-profit organizations industry. It was incorporated on 21 August 2019 (7+ years old) and is registered under CIN U85300BR2019PTC043080.
Alexmed Pharmaceuticals has 3 current directors:
- Suman Prasad Sharma - Director
- Nishi Kumari - Director
- Mukul Anand Shankar - Additional Director
The latest financial statements of Alexmed Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Alexmed Pharmaceuticals is 10AASCA6439Q1Z3, registered in Bihar.
The CIN (Corporate Identification Number) of Alexmed Pharmaceuticals is U85300BR2019PTC043080. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alexmed Pharmaceuticals was incorporated on 21 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Patna.
Mukul Anand Shankar was appointed as Additional Director on 12 Jul 2021. Nishi Kumari was appointed as Director on 21 Aug 2019. Suman Prasad Sharma was appointed as Director on 21 Aug 2019.
Yes, Alexmed Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Alexmed Pharmaceuticals is at CO Suman Prasad Vill – Jinpura Tola – Jinpura Wardi – 12 Panch – Raghopur, Patna, Bihar, India – 801111.
Alexmed Pharmaceuticals operates in the non-profit organizations industry, in the social work segment.

